Moderna has announced a deal under which it will provide 500 million doses of its mRNA COVID-19 vaccine to the global COVAX facility starting with 34 million in late 2021. The World Health Organization has also authorised the vaccine for emergency use.
Latest Video
New Stories
-
Liberty expands into Asia Pacific life sciences insurance with new tailored offering
March 25, 2026 - - Australian Biotech -
Budget delivers progress, but hundreds of thousands still waiting for access
March 25, 2026 - - Latest News -
To what extent does the system even see itself as bound by external review?
March 25, 2026 - - Latest News -
PBAC agenda reflects increasing number of companies seeking revised recommendations
March 25, 2026 - - Latest News -
Community pharmacies set to expand patient care following Labor re-election in South Australia
March 25, 2026 - - Latest News -
Clarity advances US manufacturing strategy with major copper 64 supply agreement
March 25, 2026 - -
As 'Horizon Europe' winds down, its successor program remains a work in progress
March 25, 2026 - - Latest News
